Lexicon Pharmaceuticals, Inc. - Rasio total nilai perusahaan marang pendapatan LXRX

lexpharma.com (LXRX) - logo korporat

Lexicon Pharmaceuticals (LXRX) is developing the commercial potential of sotagliflozin, expanding its cardiology pipeline. Reviewing the EV/Sales trajectory on GURU.Markets, it is evident that the parameter value is 16084.07, which assesses the value of the operating model. Success depends on physician adoption of the therapy and marketing, while protection against market behemoths is ensured by unique FDA patents on protein inhibition.

LXRX Lexicon Pharmaceuticals: Rasio nilai perusahaan marang pendapatan ing interval 23.11.2025 - 20.11.2026

lexpharma.com - rincian analitis lan metrik utama (LXRX)

Pambiji fundamental:Lexicon Pharmaceuticals, LXRX
Barang unggulan Lexicon Pharmaceuticals

This indicator allows for an assessment of the market value of Lexicon Pharmaceuticals (LXRX) by accounting for net debt relative to generated revenue streams. By analyzing the EV/Sales ratio, an investor can see the business value stripped of leverage influence. The current value of 16084.07 reflects market expectations regarding the commercialization of the drug Inpefa. The company's strong pricing power, driven by the uniqueness of SGLT1/SGLT2 inhibitors, justifies the premium nature of this metric. The trend of this indicator helps to timely identify overvalued stock prices.

Analisis pesaing Lexicon Pharmaceuticals

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Rasio total nilai perusahaan marang pendapatan MBX Corp|Altimmune Pharma - Nilai perusahaan marang pendapatan|Multiplikator EV/Sales aardvarktherapeutics.com AARD|SGMT: Nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan BIOA (BioAge Labs)|BMEA: Multiplikator EV/Sales|QNCX: Koefisien nilai perusahaan marang pendapatan|GUTS (Fractyl Health, Inc.) - Multiplikator EV/Sales|Multiplikator EV/Sales vtvtherapeutics.com|Nilai perusahaan marang pendapatan ATPC (Agape ATP Corp)|Rasio total nilai perusahaan marang pendapatan Pluristem Therapeutics|Rasio nilai perusahaan marang pendapatan synlogictx.com SYBX|LPCN: Rasio nilai perusahaan marang pendapatan|MTNB - Rasio nilai perusahaan marang pendapatan|Spruce Biosciences, Inc. (SPRB) - Nilai perusahaan marang pendapatan|GLTO: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Carmell Corp. (CTCX)|LUMO (Lumos Therapeutics) - Multiplikator EV/Sales|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)